Evidence map›Paper›PMID 41837652›Full record

ArticleMicrobiology spectrum2026

SARS-CoV-2 nonstructural protein 3 remodels the phosphorylation of target proteins via protein-protein interactions.

Hui Yang, Daxin Peng, Luis Martinez-Sobrido, Chengjin Ye

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hui YangTexas Biomedical Research Institute, San Antonio, Texas, USA.
Daxin PengCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
Luis Martinez-SobridoTexas Biomedical Research Institute, San Antonio, Texas, USA.ORCID 0000-0001-7084-0804
Chengjin YeTexas Biomedical Research Institute, San Antonio, Texas, USA.ORCID 0000-0002-1934-9494

Funding

American Lung Association ERP-1420664Texas Biomedical Forum 2023Texas Biomedical Forum 2025
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), triggered a global pandemic with a significant impact on human health. The molecular basis of its pathogenicity remains incompletely understood. The viral nucleocapsid (N) protein, the most abundant protein expressed during SARS-CoV-2 infection, is thought to contribute to disease progression. Yet, its interaction network in the context of viral infection remains largely unexplored. Here, we generated a recombinant (r)SARS-CoV-2 expressing a Strep-tagged N protein by using a reverse genetics system. Affinity purification and mass spectrometry identified an interaction between SARS-CoV-2 N protein and the nonstructural protein 3 (NSP3). Domain mapping revealed that the N dimerization domain and the N-terminal region of NSP3 mediate this interaction. Notably, an N protein mutant lacking its N-terminal domain exhibited enhanced binding to NSP3 and underwent dephosphorylation, implicating NSP3 as a potential viral phosphatase. We further found that NSP3 interacts with interferon regulatory factor 3 (IRF3), a key transcription factor involved in host type I interferon (IFN-α/β) antiviral response. SARS-CoV-2 NSP3 expression suppressed poly(I:C)-induced IRF3 phosphorylation and broadly reduced cellular phosphorylation levels in a dose-dependent manner. These findings suggest that SARS-CoV-2 NSP3 modulates host phosphorylation dynamics to subvert antiviral signaling and facilitate viral replication. IMPORTANCE: Understanding host-virus and virus-virus interactions is essential for uncovering mechanisms of viral replication and immune evasion, and for identifying targets for rational antiviral intervention. While previous screens using individually expressed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins have revealed host factors involved in infection, they could not capture virus-virus protein interactions or virus-host interactions in the context of infection. Here, we engineered a recombinant (r)SARS-CoV-2 expressing a Strep-tagged nucleocapsid (N) protein to identify viral protein interactions with SARS-CoV-2 during active infection. We identified an interaction between the viral N protein and the nonstructural protein 3 (NSP3) and uncovered a previously unrecognized role for NSP3 in regulating viral and host protein phosphorylation, interaction with interferon regulatory factor 3 (IRF3), and regulation of innate immune response. This work highlights a powerful approach for dissecting protein interaction networks occurring during SARS-CoV-2 infection and suggests new targets for therapeutic development against SARS-CoV-2.

Indexed as

Coronavirus Nucleocapsid ProteinsCOVID-19SARS-CoV-2Viral Nonstructural ProteinsHEK293 CellsHumansInterferon Regulatory Factor-3PhosphoproteinsPhosphorylationProtein BindingVirus ReplicationCoronavirus Nucleocapsid ProteinsInterferon Regulatory Factor-3IRF3 protein, humannucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsViral Nonstructural ProteinsIRF3NSP3nucleocapsid proteinSARS-CoV-2Strep-tag

Identifiers

PMID41837652
PMCPMC13055223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.